Fundraising FoxSofinnova Partners — 2024 Investments
11 investments dated 2024 · listed companies and verified rows first · show all
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.
BiotechDigital HealthHealthtechMedical Devices
Moin Saleem(Co-founder & Chief Scientific Advisor)in
Co-investorsForbionGilde HealthcareAdvent Life SciencesBritish Patient Capital
Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.
AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US
Alexandre Zanghellini(Co-Founder & Chief Executive Officer)inEric Althoff(Executive Officer, Director, Promoter)inDavid Baker(Co-founder and Scientific Advisor)Bill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)
Co-investorsCirculate CapitalFall Line CapitalSustainable Conversion VenturesContinental Grain CompanyLewis & Clark AgriFoodOS Fund+2 more
Bioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation.
AI & Machine LearningBiotechDigital HealthHealthtechParis, FR
Eric Durand(Founder)inFelipe Llinares-López(Co-founder & VP of AI)inRodolphe Jenatton(Founder)inZelda Mariet(Founder)inJean-Philippe Vert(Founder)inDavid Cahané(Co-founder & General Manager)
Co-investorsAndera PartnersCathay InnovationFELIX CAPITALFrstHeadlineHeadline Growth Management, LLC+8 more
Cure51 is a cancer research company that decodes the biology of exceptional cancer survivors ("cancer outliers") using molecular profiling and computational biology, collecting patient data on its Patient Profile Platform.
AI & Machine LearningBiotechDigital HealthHealthtech
Paloma Cejas(Founder, Head of Translational Research)inRémy Nicolle(Founder, Senior Advisor Computational Biology)
Co-investorsHitachi VenturesKima VenturesLifeX Ventures
Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts).
HardwareHealthtechMedical Devices
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.
BiotechDeep TechMedical DevicesBoston, US
Luke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)David Liu, PhD(Founder)Angelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)Jonathan Weissman, PhD
Co-investorsAtlas VentureNewpath Partners5AM VenturesARCH Venture PartnersDCVC (Data Collective)F-Prime Capital+11 more
NovaMeat develops plant-based protein food products, positioning them as part of a new culinary tradition.
FoodTech
Giuseppe Scionti(Founder)in
Co-investorsAurum Venture PartnersCarbonJoyance PartnersUnovis Asset ManagementVU Venture PartnersForbion+1 more
Qorium develops cell-cultured leather grown from a single animal cell sample, producing uniform collagen sheets that integrate into existing tannery and leather-goods production processes.
BiotechCircular EconomyNew Materials
Co-investorsBrightlands Venture PartnersInvest-NL
Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.
Co-investorsInvusREDMILESanofi Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Disco PharmaceuticalsDMC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.